120 related articles for article (PubMed ID: 11518010)
21. Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pure progressive autonomic failure.
Yoshida M; Fukumoto Y; Kuroda Y; Ohkoshi N
Eur Neurol; 1997; 38(4):291-6. PubMed ID: 9434088
[TBL] [Abstract][Full Text] [Related]
22. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
23. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.
Sisson JC; Shapiro B; Meyers L; Mallette S; Mangner TJ; Wieland DM; Glowniak JV; Sherman P; Beierwaltes WH
J Nucl Med; 1987 Oct; 28(10):1625-36. PubMed ID: 3655915
[TBL] [Abstract][Full Text] [Related]
24. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease.
Oka H; Yoshioka M; Morita M; Onouchi K; Suzuki M; Ito Y; Hirai T; Mochio S; Inoue K
Neurology; 2007 Oct; 69(14):1460-5. PubMed ID: 17909159
[TBL] [Abstract][Full Text] [Related]
25. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
Marini C; Giorgetti A; Gimelli A; Kusch A; Sereni N; L'abbate A; Marzullo P; Sambuceti G
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):682-8. PubMed ID: 15747157
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
[TBL] [Abstract][Full Text] [Related]
27. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
[TBL] [Abstract][Full Text] [Related]
28. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
29. Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG.
Giordano A; Calcagni ML; Verrillo A; Pellegrinotti M; Frontoni S; Spallone V; Gambardella S
Diabetes Nutr Metab; 2000 Dec; 13(6):350-5. PubMed ID: 11232761
[TBL] [Abstract][Full Text] [Related]
30. [Usefulness of myocardial imaging by 123I-MIBG in assessment of diabetic neuropathy].
Katono E; Owada K; Takeda H; Techigawara M; Watanabe N; Maruyama Y
Kaku Igaku; 1993 Oct; 30(10):1235-9. PubMed ID: 8264114
[TBL] [Abstract][Full Text] [Related]
31. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].
Satoh A; Serita T; Tsujihata M
Nihon Rinsho; 1997 Jan; 55(1):202-6. PubMed ID: 9014450
[TBL] [Abstract][Full Text] [Related]
32. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis.
Hongo M; Urushibata K; Kai R; Takahashi W; Koizumi T; Uchikawa S; Imamura H; Kinoshita O; Owa M; Fujii T
Am Heart J; 2002 Jul; 144(1):122-9. PubMed ID: 12094198
[TBL] [Abstract][Full Text] [Related]
33. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability.
Delahaye N; Dinanian S; Slama MS; Mzabi H; Samuel D; Adams D; Merlet P; Le Guludec D
Eur J Nucl Med; 1999 Apr; 26(4):416-24. PubMed ID: 10199949
[TBL] [Abstract][Full Text] [Related]
34. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
[TBL] [Abstract][Full Text] [Related]
35. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
[TBL] [Abstract][Full Text] [Related]
36. Sympathetic overactivity in uremia detected by 123I-MIBG scintigraphy.
Andersen KF; Enevoldsen LH
Clin Nucl Med; 2008 Nov; 33(11):790-1. PubMed ID: 18936617
[No Abstract] [Full Text] [Related]
37. Cardiac autonomic dysfunction in Brugada syndrome.
Wichter T; Matheja P; Eckardt L; Kies P; Schäfers K; Schulze-Bahr E; Haverkamp W; Borggrefe M; Schober O; Breithardt G; Schäfers M
Circulation; 2002 Feb; 105(6):702-6. PubMed ID: 11839625
[TBL] [Abstract][Full Text] [Related]
38. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
[TBL] [Abstract][Full Text] [Related]
39. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
40. Cardiac neurotransmission imaging with 123I-meta-iodobenzylguanidine in postural tachycardia syndrome.
Haensch CA; Lerch H; Schlemmer H; Jigalin A; Isenmann S
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):339-43. PubMed ID: 19687022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
